Y6X-10539-26937
4 vaccinations
1 coded response
37 check-ins
1 free-text entry
0 call cases
- Sex
- Female
- Age at first dose
- 26-30
- ZIP prefix
- 212 / MD
- Registered
- 2020-12-28
- Relationship
- Self
- Race
- White
- Ethnicity
- Not Hispanic or Latino
Registered dependents
EQA-27398-29842
Child or adolescent in my care · Female · 2022-06-24
Timeline
-
2020-12-26
Dose 1 — Pfizer-BioNTech
-
2020-12-28
Registered in v-safe
- 2020-12-28
- 2020-12-29
- 2020-12-30
- 2020-12-31
- 2021-01-01
- 2021-01-02
- 2021-01-09
-
2021-01-16
Dose 2 — Pfizer-BioNTech
- 2021-01-16
- 2021-01-17
- 2021-01-18
- 2021-01-19
- 2021-01-20
- 2021-01-21
- 2021-01-22
- 2021-01-23
- 2021-01-30
- 2021-02-06
- 2021-02-13
- 2021-02-22
- 2021-02-27
-
2021-04-17
Survey response — 3 months, dose 2MedDRA: Pre-existing disease — Feeling: GoodFree text: PreeclampsiaMedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
- 2021-07-18
-
2021-10-06
Dose 3 — Pfizer-BioNTech
- 2022-01-16
-
2022-09-17
Dose 4 — Pfizer-BioNTech
- 2022-09-17
- 2022-09-18
- 2022-09-19
- 2022-09-20
- 2022-09-21
- 2022-09-22
- 2022-09-23
- 2022-09-24
- 2022-10-01
- 2022-10-11
- 2022-10-15
- 2022-10-24
- 2022-10-29
- 2022-12-18
Vaccinations
| Dose | Date | Manufacturer | Co-administered |
|---|---|---|---|
| 1 | 2020-12-26 | Pfizer-BioNTech | |
| 2 | 2021-01-16 | Pfizer-BioNTech | |
| 3 | 2021-10-06 | Pfizer-BioNTech | No |
| 4 | 2022-09-17 | Pfizer-BioNTech | No |
Free text
Release 7 — 3 months, dose 2
Symptoms: Preeclampsia
Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".
MedDRA terms by release
| Field | Preferred term | 2021-09 | 2023-04 | 2024-11 |
|---|---|---|---|---|
| SD | Pre-existing disease | ✓ | ✓ | ✓ |
✓ active code · ○ coded but marked inactive · blank = not in that release